- Home
- APGE vs STRA Comparison
APGE vs STRA Comparison
Compare APGE & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- STRA
- Stock Information
- Founded
- APGE 2022
- STRA 2017
- Country
- APGE United States
- STRA United States
- Employees
- APGE N/A
- STRA N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- STRA Other Consumer Services
- Sector
- APGE Health Care
- STRA Real Estate
- Exchange
- APGE Nasdaq
- STRA Nasdaq
- Market Cap
- APGE 1.8B
- STRA 2.0B
- IPO Year
- APGE 2023
- STRA 1996
- Fundamental
- Price
- APGE $39.72
- STRA $85.66
- Analyst Decision
- APGE Strong Buy
- STRA Strong Buy
- Analyst Count
- APGE 4
- STRA 3
- Target Price
- APGE $91.33
- STRA $112.33
- AVG Volume (30 Days)
- APGE 789.9K
- STRA 188.7K
- Earning Date
- APGE 03-03-2025
- STRA 04-24-2025
- Dividend Yield
- APGE N/A
- STRA 2.80%
- EPS Growth
- APGE N/A
- STRA 60.48
- EPS
- APGE N/A
- STRA 4.67
- Revenue
- APGE N/A
- STRA $1,219,930,000.00
- Revenue This Year
- APGE N/A
- STRA $6.40
- Revenue Next Year
- APGE $795.25
- STRA $4.85
- P/E Ratio
- APGE N/A
- STRA $18.34
- Revenue Growth
- APGE N/A
- STRA 7.68
- 52 Week Low
- APGE $29.10
- STRA $78.43
- 52 Week High
- APGE $68.21
- STRA $123.62
- Technical
- Relative Strength Index (RSI)
- APGE 55.27
- STRA 49.67
- Support Level
- APGE $38.18
- STRA $82.19
- Resistance Level
- APGE $41.07
- STRA $86.35
- Average True Range (ATR)
- APGE 2.31
- STRA 1.90
- MACD
- APGE 0.22
- STRA 1.17
- Stochastic Oscillator
- APGE 63.77
- STRA 90.97
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About STRA Strategic Education Inc.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.